Handa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Handa Pharmaceuticals has a total shareholder equity of NT$2.8B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$3.0B and NT$280.9M respectively. Handa Pharmaceuticals's EBIT is NT$693.4M making its interest coverage ratio -38.7. It has cash and short-term investments of NT$2.3B.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -38.7x |
| Cash | NT$2.32b |
| Equity | NT$2.76b |
| Total liabilities | NT$280.88m |
| Total assets | NT$3.04b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6620's short term assets (NT$2.7B) exceed its short term liabilities (NT$209.5M).
Long Term Liabilities: 6620's short term assets (NT$2.7B) exceed its long term liabilities (NT$71.4M).
Debt to Equity History and Analysis
Debt Level: 6620 is debt free.
Reducing Debt: 6620 has no debt compared to 5 years ago when its debt to equity ratio was 0.4%.
Debt Coverage: 6620 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6620 has no debt, therefore coverage of interest payments is not a concern.